Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvanted Influenza Vaccination and Morbidity and Mortality in U.S. Nursing Homes

NCT02882100 is registered in ClinicalTrials.gov with Insight Therapeutics, LLC as lead sponsor.

NCT NCT02882100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02882100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvanted Influenza Vaccination and Morbidity and Mortality in U.S. Nursing Homes
Lead sponsor
Insight Therapeutics, LLC
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2016
Completion date
January 25, 2023
Enrollment
823 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, influenza-like illness